|Bid||0.00 x 800|
|Ask||0.00 x 1200|
|Day's Range||17.38 - 19.13|
|52 Week Range||11.70 - 48.75|
|Beta (5Y Monthly)||2.51|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 27, 2023 - Mar 03, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||44.50|
Whilst it may not be a huge deal, we thought it was good to see that the Arcturus Therapeutics Holdings Inc...
The latest analyst coverage could presage a bad day for Arcturus Therapeutics Holdings Inc. ( NASDAQ:ARCT ), with the...
Arcturus Therapeutics Holdings ( NASDAQ:ARCT ) Third Quarter 2022 Results Key Financial Results Revenue: US$13.4m (up...